-
-
-
-
-
-
-
Bernstein SocGen Group Starts Immunovant (IMVT) at Market Perform
-
-
-
-
-
-
-
Jefferies Reiterates Buy Rating on Roivant Sciences (ROIV) amid Brepocitinib NDA acceptance
-
-
-
-
-
-
-
Roivant Sciences (ROIV) PT Raised to $26 at H.C. Wainwright
-
-
-
-
-
-
-
Roivant Sciences Ltd. (ROIV) Tops Q2 EPS by 15c
-
-
-
-
-
-
-
Roivant Sciences (ROIV) PT Raised to $24 at Goldman Sachs
-
-
-
-
-
-
-
Roivant Sciences (ROIV) PT Raised to $18 at Leerink Partners
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Roivant Sciences (ROIV)
-
416,750 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

